Home  »  Trending   »  Bristol-Myers Squibb Company (BMY) Just Got Our At...

Bristol-Myers Squibb Company (BMY) Just Got Our Attention

Bristol-Myers Squibb Company (NYSE:BMY) went up by 0.36% from its latest closing price compared to the recent 1-year high of $81.17. The company’s stock price has collected 3.93% of gains in the last five trading sessions. Barron’s reported on 09/12/22 that Bristol Myers, Carvana, MicroStrategy, Adobe, and More Stock Market Movers

Is It Worth Investing in Bristol-Myers Squibb Company (NYSE :BMY) Right Now?

Bristol-Myers Squibb Company (NYSE:BMY) scored a price-to-earnings ratio above its average ratio, recording 25.80 x from its present earnings ratio. Plus, the 36-month beta value for BMY is at 0.39. Opinions of the stock are interesting as 9 analysts out of 22 who provided ratings for Bristol-Myers Squibb Company declared the stock was a “buy,” while 1 rated the stock as “overweight,” 11 rated it as “hold,” and 1 as “sell.”

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


The average price from analysts is $80.33, which is $1.74 above the current price. BMY currently public float of 2.12B and currently shorts hold a 1.17% ratio of that float. Today, the average trading volume of BMY was 9.94M shares.

BMY’s Market Performance

BMY stocks went up by 3.93% for the week, with a monthly jump of 8.75% and a quarterly performance of 10.69%, while its annual performance rate touched 37.75%. The volatility ratio for the week stands at 1.56% while the volatility levels for the past 30 days are set at 2.21% for Bristol-Myers Squibb Company. The simple moving average for the period of the last 20 days is 2.03% for BMY stocks with a simple moving average of 7.79% for the last 200 days.

Analysts’ Opinion of BMY

Many brokerage firms have already submitted their reports for BMY stocks, with Credit Suisse repeating the rating for BMY by listing it as a “Neutral.” The predicted price for BMY in the upcoming period, according to Credit Suisse is $78 based on the research report published on November 18th of the current year 2022.

Berenberg gave a rating of “Hold” to BMY, setting the target price at $76 in the report published on September 14th of the current year.

BMY Trading at 7.63% from the 50-Day Moving Average

After a stumble in the market that brought BMY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.50% of loss for the given period.

Volatility was left at 2.21%, however, over the last 30 days, the volatility rate increased by 1.56%, as shares surge +6.30% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +12.30% upper at present.

During the last 5 trading sessions, BMY rose by +3.93%, which changed the moving average for the period of 200-days by +20.11% in comparison to the 20-day moving average, which settled at $77.80. In addition, Bristol-Myers Squibb Company saw 26.93% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at BMY starting from Powell Ann, who sale 16,250 shares at the price of $80.45 back on Nov 09. After this action, Powell Ann now owns 34,226 shares of Bristol-Myers Squibb Company, valued at $1,307,312 using the latest closing price.

VESSEY RUPERT, the EVP, Research & Early Dev. of Bristol-Myers Squibb Company, sale 45,910 shares at $78.88 during a trade that took place back on Nov 07, which means that VESSEY RUPERT is holding 57,079 shares at $3,621,381 based on the most recent closing price.

Stock Fundamentals for BMY

Current profitability levels for the company are sitting at:

  • +20.57 for the present operating margin
  • +57.69 for the gross margin

The net margin for Bristol-Myers Squibb Company stands at +15.08. Equity return is now at value 20.10, with 6.50 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 1.52.